Postdoc In Translational Oncolytic Viro-/Immunotherapy (M/F/D)

The position

ViraTherapeutics is a subsidiary of the Boehringer Ingelheim group of companies: a perfect symbiosis of big pharma and a biotech start-up vibe. Located in the beautiful city of Innsbruck (Rum), Austria – a great place to live and to work – our dedicated Research team develops innovative viral-based immune-oncology treatment options.

We are looking for an enthusiastic, highly motivated, and hands-on Postdoc in translational oncolytic Viro-/Immunotherapy. In this science-focused position, you will be an integral driver of a translational science hub de-convoluting early anti-cancer research concepts.

Tasks & responsibilities

• Investigate mechanisms of actions of oncolytic viruses by extending existing and developing new human and murine flow cytometry assays
• Characterize virus particles by implementing a new flow virometry assay
• Optimize methods for in vivo expansion and activation of immune cells and oncolytic viruses
• Self-motivated knowledge management in the field (based on scientific network and deep literature oversight) to propose and implement innovative methods and evaluation concepts
• Interact and communicate proactively within a highly dynamic external research network including partners from academia, industry, and the local clinical surgery departments (including presentations of the project work at scientific conferences)

Requirements

• PhD, PharmD, or MD/PhD in Immunology, Biology, Biochemistry, Molecular Medicine, Virology, or a related field with at least 4 years of experience
• Hands-on experience and in-depth knowledge in basic and advanced flow cytometry is a must
• Experience in small particle analysis/flow cytometry is a strong asset
• Experience working with patient samples is a plus
• Sound knowledge of cancer immunology, cancer immunotherapy and ex vivo assays is preferred
• Strong team player with excellent interpersonal and clear communication skills are essential to integrate in a multi-disciplinary, lively, and flexible team
• Evidence of scientific rigor as documented by first author peer-reviewed publications
• Fluency in English, both spoken and written; German language skills would be highly appreciated (otherwise willingness to learn German)

Your Benefits

• 3-year fixed-term contract. Access to Boehringer Ingelheim’s PostDoc program
• We offer a responsible and versatile occupation in an ambitious international team that has fun at work, a friendly and appreciative working atmosphere in a bright and modern working environment
• You will have the unique possibility to drive research towards a novel cancer therapy at the interface of science and translation being part of an engaged scientific team
• Aspirate the passionate, science-driven atmosphere of a small biotech company with flat hierarchies, short decision-making paths and the opportunity to contribute your own ideas, whilst benefiting from being part of the global group of Boehringer Ingelheim, one of the pharmaceutical industry’s top 20 companies worldwide
• We offer an attractive salary plus allowances and benefits package, flexible working times and great team spirit. As well as attractive social benefits (e.g. public transport ticket, meal allowance, team events, health and sports offers).

The minimum gross annual salary according to the collective bargaining agreement for this position is EUR 70.000 (full time), although the actual salary is based on your technical skills and personal competencies as well as your professional experience.

We are looking forward to receiving your application online!

By uploading your application documents via our application portal, we can treat your data confidentially and in compliance with the GDPR.
Do you have any additional questions about the position? Your HR Recruiting Manager for this position is Anja Diestel.

On our career site you will find further information about us as an employer as well as information about the application process or our diverse divisions. Take a look behind the scenes and get an insight into our day-to-day business.